Search research articles
Contact Us
Filters
Showing results (121-130 of 134) with videos related to
Page
of 14
Sort By:
The American Journal of Cardiology
|
September 1, 2021
Preservation of Cardiac Reserve and Cardiorespiratory Fitness in Patients With Acute De Novo Versus Acute on Chronic Heart Failure With Reduced Ejection Fraction
Marco Giuseppe Del Buono, Virginia Mihalick, Juan Ignacio Damonte, et al.
JACC. Advances
|
May 14, 2026
SGLT2 Inhibitors in Cardio-Oncology: A Systematic Review and Meta-Analysis
Luigi Spadafora, Marco Bernardi, Gianmarco Sarto, et al.
JPEN. Journal of Parenteral and Enteral Nutrition
|
October 23, 2020
Clinical Nutrition Research and the COVID-19 Pandemic: A Scoping Review of the ASPEN COVID-19 Task Force on Nutrition Research
Jeffrey I Mechanick, Salvatore Carbone, Roland N Dickerson, et al.
The American Journal of Cardiology
|
December 9, 2014
Comparative safety of interleukin-1 blockade with anakinra in patients with ST-segment elevation acute myocardial infarction (from the VCU-ART and VCU-ART2 pilot studies)
Antonio Abbate, Michael Christopher Kontos, Nayef Antar Abouzaki, et al.
Cells
|
May 16, 2023
Change in Eosinophil Count in Patients with Heart Failure Treated with Anakinra
Michele Golino, Francesco Moroni, Marco Giuseppe Del Buono, et al.
Journal of Cardiovascular Pharmacology
|
November 25, 2020
Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II-III Systolic Heart Failure
George F Wohlford, Benjamin W Van Tassell, Hayley E Billingsley, et al.
Journal of Cardiovascular Pharmacology
|
February 25, 2016
Interleukin-1 Blockade in Acute Decompensated Heart Failure: A Randomized, Double-Blinded, Placebo-Controlled Pilot Study
Benjamin W Van Tassell, Nayef A Abouzaki, Claudia Oddi Erdle, et al.
The American Journal of Cardiology
|
November 8, 2015
Usefulness of C-Reactive Protein Plasma Levels to Predict Exercise Intolerance in Patients With Chronic Systolic Heart Failure
Justin McNair Canada, Daniel Taylor Fronk, Laura Freeman Cei, et al.
Circulation. Heart Failure
|
November 17, 2017
Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure: Results From REDHART (Recently Decompensated Heart Failure Anakinra Response Trial)
Benjamin W Van Tassell, Justin Canada, Salvatore Carbone, et al.
Circulation. Heart Failure
|
September 13, 2022
Sarcopenic Obesity Is Associated With Reduced Cardiorespiratory Fitness Compared With Nonsarcopenic Obesity in Patients With Heart Failure With Reduced Ejection Fraction
Hayley E Billingsley, Marco Giuseppe Del Buono, Justin M Canada, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 134) with videos related to
Sort By:
Page
of 14
The American Journal of Cardiology
|
September 1, 2021
Preservation of Cardiac Reserve and Cardiorespiratory Fitness in Patients With Acute De Novo Versus Acute on Chronic Heart Failure With Reduced Ejection Fraction
Marco Giuseppe Del Buono, Virginia Mihalick, Juan Ignacio Damonte, et al.
JACC. Advances
|
May 14, 2026
SGLT2 Inhibitors in Cardio-Oncology: A Systematic Review and Meta-Analysis
Luigi Spadafora, Marco Bernardi, Gianmarco Sarto, et al.
JPEN. Journal of Parenteral and Enteral Nutrition
|
October 23, 2020
Clinical Nutrition Research and the COVID-19 Pandemic: A Scoping Review of the ASPEN COVID-19 Task Force on Nutrition Research
Jeffrey I Mechanick, Salvatore Carbone, Roland N Dickerson, et al.
The American Journal of Cardiology
|
December 9, 2014
Comparative safety of interleukin-1 blockade with anakinra in patients with ST-segment elevation acute myocardial infarction (from the VCU-ART and VCU-ART2 pilot studies)
Antonio Abbate, Michael Christopher Kontos, Nayef Antar Abouzaki, et al.
Cells
|
May 16, 2023
Change in Eosinophil Count in Patients with Heart Failure Treated with Anakinra
Michele Golino, Francesco Moroni, Marco Giuseppe Del Buono, et al.
Journal of Cardiovascular Pharmacology
|
November 25, 2020
Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II-III Systolic Heart Failure
George F Wohlford, Benjamin W Van Tassell, Hayley E Billingsley, et al.
Journal of Cardiovascular Pharmacology
|
February 25, 2016
Interleukin-1 Blockade in Acute Decompensated Heart Failure: A Randomized, Double-Blinded, Placebo-Controlled Pilot Study
Benjamin W Van Tassell, Nayef A Abouzaki, Claudia Oddi Erdle, et al.
The American Journal of Cardiology
|
November 8, 2015
Usefulness of C-Reactive Protein Plasma Levels to Predict Exercise Intolerance in Patients With Chronic Systolic Heart Failure
Justin McNair Canada, Daniel Taylor Fronk, Laura Freeman Cei, et al.
Circulation. Heart Failure
|
November 17, 2017
Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure: Results From REDHART (Recently Decompensated Heart Failure Anakinra Response Trial)
Benjamin W Van Tassell, Justin Canada, Salvatore Carbone, et al.
Circulation. Heart Failure
|
September 13, 2022
Sarcopenic Obesity Is Associated With Reduced Cardiorespiratory Fitness Compared With Nonsarcopenic Obesity in Patients With Heart Failure With Reduced Ejection Fraction
Hayley E Billingsley, Marco Giuseppe Del Buono, Justin M Canada, et al.
Page
of 14